The ST Group of Companies has acquired a tissue paper mill in Barnwell County, South Carolina, from Cascades. The deal was signed through ST’s new subsidiary, Barnwell Tissue Solutions. The mill, equipped with a 110-inch Valmet hybrid QRT/DCT tissue machine installed in 2016, can produce 30,000 tons annually. The company will manufacture large paper rolls from recycled paper, which will be converted into different tissue products. The investment amounts to $12 million, and will create 50 jobs, according to Gov. Henry McMaster’s office. “Barnwell Tissue Solutions, a proud member of the ST Group of companies, is honored to expand our manufacturing footprint into Barnwell, South Carolina,” said Barnwell Tissue Solutions Owner Sahil Tak, as quoted by Columbia Business Monthly.

AptarGroup, Inc. announced that it has entered into exclusive negotiations with respect to a potential acquisition of all outstanding shares of Voluntis (ENXTPA: ALVTX), a pioneer in digital therapeutics. This acquisition would complement Aptar’s existing digital health portfolio of connected devices by adding digital therapeutic solutions and broadening its digital health services across multiple chronic conditions and diseases. Digital therapeutics (DTx) help patients and caregivers treat, manage, or prevent a disorder or disease through evidence-based interventions that are driven by high quality software solutions. Supported by the trend toward personalized healthcare, DTx are used independently or in connection with medications, devices or other therapies to optimize patient care and health outcomes. By acquiring Voluntis, Aptar would have immediate access to an established proprietary platform and algorithms that would drive future digital solutions provided to pharmaceutical and biotech customers as well as other healthcare stakeholders including payers and providers.

Amcor CEO Ron Delia said: “Fiscal 2022 was another outstanding year for Amcor. Our financial performance accelerated throughout the year as we delivered our strongest quarter in June with organic sales growth of 6% and adjusted EBIT growth of 9%. For the full year, strong execution resulted in 11% adjusted EPS growth, at the top end of our guidance range and supported by organic sales growth of 4%. We generated over $1 billion in adjusted free cash flow, supporting $600 million in share repurchases and an increase in what we believe is a very compelling dividend." “This is our third consecutive year of accelerating top line growth, and we expect to sustain this momentum including by stepping up investments in areas such as higher value-add priority segments. This gives us confidence the business will deliver another year of strong underlying EPS growth in the range of 7% to 12%. We also plan to continue returning capital to shareholders while actively exploring opportunities for value-creating acquisitions across our portfolio."